文献速递头颈部肿瘤放疗

头颈部恶性肿瘤三次及以上放疗的疗效与安全性

Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies.
PubMed 文献 · Clin Transl Radiat Oncol · 2020-04-24

PURPOSE: Recurrent head and neck cancers are associated with significant morbidity and mortality. Outcomes of multiple courses of radiation have not yet been described.…

要点

  • 头颈部≥3程放疗可行但毒性显著,≥3级毒性达45%、≥4级达21%。
  • 末次再程放疗后中位局部无复发生存9.1个月,中位总生存10个月。
  • 需多学科团队管理,并权衡局部控制与新兴全身治疗机会。

核心结论

  • 头颈部重复再程放疗可行,但伴随显著风险,适合多学科团队管理并权衡局部控制与全身治疗机会。

研究设计与样本

  • 单中心数据库回顾性查询,回顾治疗计划并选择头颈部区域接受≥3程放疗的患者。

主要发现

  • 末次再程放疗后中位局部无复发生存为9.1个月,中位总生存为10个月。
  • 15例(45%)报告≥3级毒性,7例(21%)报告≥4级毒性,无5级毒性。
  • 20例(61%)在完成重复再程放疗后接受后续治疗。

关键数值与推荐

  • ≥3级毒性见于15例(45%),≥4级毒性见于7例(21%),无5级毒性。
  • 末次再程放疗后中位局部无复发生存9.1个月,中位总生存10个月。

临床怎么用

  • 对头颈部多程放疗患者应由多学科团队评估与管理,并权衡局部控制与全身治疗机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Recurrent head and neck cancers are associated with significant morbidity and mortality. Outcomes of multiple courses of radiation have not yet been described. METHODS AND MATERIALS: A single institution database was queried to retrospectively review treatment plans and select patients who underwent ≥ 3 courses of radiation to the head and neck region. RESULTS: Thirty-three patients were found to have ≥ 3 courses of radiation with overlapping fields. Median local recurrence free survival after last course of reirradiation was 9.1 months and median overall survival was 10 months. Grade 3 and above toxicities were reported in 15 patients (45%). Grade 4 and above toxicities were reported in seven patients (21%). There was no grade 5 toxicity. 20 patients (61%) underwent subsequent therapies following completion of repeat reirradiation. CONCLUSIONS: Repeat reirradiation to the head and neck region is feasible and carries significant risks that are most appropriately managed with a multi-disciplinary team and must be balanced against the potential for local control and opportunities for emerging systemic therapies.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Xu AJ, Luo L, Leeman JE, et al. Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies. Clin Transl Radiat Oncol. 2020. PMID: 32382663. doi:10.1016/j.ctro.2020.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。